Israel’s Todos (see here previously) completed a Phase 2 study of its Tollovir treatment on 31 hospitalized Covid-19 patients. Their clinical improvement was 2.7 days faster than the placebo group. Jerusalem’s Shaare Zedek hospital is now allowing Tollovir for compassionate … Continue reading →

Israeli biotech Todos Medical has developed the “Total Biochemical Infrared Analysis” (TBIA) method for screening of solid tumors. The patient’s white blood cells are exposed to a spectrum of light. Analysis of the results reveals where the immune system has … Continue reading →